Atara Biotherapeutics, Inc.
ATRA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$85,403 | -$276,126 | -$228,302 | -$340,141 |
| Dep. & Amort. | $5,051 | $4,829 | $5,653 | $9,345 |
| Deferred Tax | $0 | $0 | $0 | $1,790 |
| Stock-Based Comp. | $27,001 | $45,386 | $53,838 | $53,865 |
| Change in WC | -$30,959 | $15,341 | -$61,468 | $52,584 |
| Other Non-Cash | $15,593 | $17,593 | -$40,151 | $2,035 |
| Operating Cash Flow | -$68,717 | -$192,977 | -$270,430 | -$220,522 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$246 | -$1,223 | -$4,193 | -$10,580 |
| Net Acquisitions | $0 | $0 | $0 | -$32,838 |
| Inv. Purchases | -$19,665 | -$83,648 | -$180,589 | -$301,129 |
| Inv. Sales/Matur. | $28,535 | $208,712 | $292,973 | $333,967 |
| Other Inv. Act. | $0 | $25 | $94,765 | $32,838 |
| Investing Cash Flow | $8,624 | $123,866 | $202,956 | $22,258 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$892 | -$947 | -$518 | -$254 |
| Stock Issued | $59,951 | $2,136 | $21,891 | $98,697 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $223 | $821 | $31,711 | $5,501 |
| Financing Cash Flow | $59,282 | $2,010 | $53,084 | $103,944 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$811 | -$67,101 | -$14,390 | -$94,320 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $25,987 | $93,088 | $107,478 | $201,798 |
| End Cash | $25,176 | $25,987 | $93,088 | $107,478 |
| Free Cash Flow | -$68,963 | -$194,200 | -$274,623 | -$231,102 |